Kowa Research Institute, Inc.
Clinical trials sponsored by Kowa Research Institute, Inc., explained in plain language.
-
New hope for liver disease patients who Don't respond to standard treatments
Disease control OngoingThis study tests two doses of a drug called K-808 (pemafibrate) in 46 adults with primary biliary cholangitis, a chronic liver disease. Participants had an inadequate response to standard treatments like ursodeoxycholic acid or obeticholic acid. The main goal is to see if K-808 c…
Phase: PHASE2 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug cocktail aims to halt liver scarring in NASH patients
Disease control OngoingThis study tests whether a combination of two experimental drugs can improve liver health in adults with NASH, a fatty liver disease that can lead to scarring. About 228 participants with mild to moderate liver scarring will take the drugs for up to a year. The main goal is to se…
Phase: PHASE2 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC